HealthcareTechnology

Rapid Genetic Testing Revolutionizes Critical Care Diagnoses in ICU Settings

A groundbreaking medical study demonstrates how ultrarapid long-read genome sequencing can provide life-changing genetic diagnoses for ICU patients in under a week. The technology has already enabled immediate treatment adjustments for 64% of diagnosed patients, transforming critical care decision-making.

Breakthrough in Critical Care Genetics

Medical researchers have implemented a revolutionary diagnostic approach that delivers genetic answers for critically ill patients in record time, according to reports published in the European Journal of Human Genetics. The ultrarapid long-read genome sequencing (LR-GS) pipeline achieved a median turnaround time of just 5.3 days compared to 18.4 days for standard genomic care, potentially transforming outcomes for patients in intensive care units.

StartupsTechnology

NeuroBell CEO Honored as Top Startup Founder for Neonatal Brain Monitor Innovation

NeuroBell CEO Mark O’Sullivan has been named Enterprise Ireland’s HPSU Founder of the Year for developing Luna, a portable brain monitor with AI-powered seizure detection. The medical device enables neonatal ICU staff to quickly diagnose seizures in infants without requiring subspecialty expertise. The award recognizes the startup’s rapid growth and global expansion plans.

Neonatal Medical Technology Breakthrough Earns Top Startup Honor

Mark O’Sullivan, co-founder and CEO of medical technology company NeuroBell, has been awarded the prestigious Enterprise Ireland High-Potential Start-up Founder of the Year title, according to reports from the recent awards ceremony. The recognition comes for his work on Luna, a portable brain monitoring device that helps neonatal intensive care staff quickly detect seizures in infants.